B

Brainstorm Cell Therapeutics
D

BCLI

2.09000
USD
-0.17
(-7.52%)
Market Open
Volume
1,310
EPS
-2
Div Yield
-
P/E
-1
Market Cap
11,920,160
Arincen Network provides with latest BRAINSTORM CELL THERAPEUTICS (BCLI) Stock signals produced by our trading experts. The latest BRAINSTORM CELL THERAPEUTICS (BCLI) analysis and signals are vital for professional traders. Our signals feed produced by Arincen traders; you can follow top traders based on their signals history and trading performance, and reputation.
There is currently no data in this area.